DOI QR코드

DOI QR Code

Preparation and Release Properties of Oromucosal Moisture-activated Patches Containing Lidocaine or Ofloxacin

오플록사신 및 리도카인 함유 수분 감응성 구강점막 패취제의 제조 및 방출 특성

  • 곽혜선 (이화여자대학교 약학대학) ;
  • 송연화 (동덕여자대학교 약학대학) ;
  • 전인구 (동덕여자대학교 약학대학)
  • Published : 2005.12.20

Abstract

This study was aimed to design and formulate the moisture-activated patches containing ofloxacin and lidocaine for antibacterial and local anesthetic action. The solubility of lidocaine at $32^{\circ}C$ in various vehicles decreased in the rank order of PG $759.5{\pm}44.5\;mg/mL$ > PGL > IPM > PEG 300 > PEG 400 > Ethanol > PGMC > DGME > PGML > OA > $Captex^{\circledR}\;300$ > $Captex^{\circledR}\;200$ > water $(4.0{\pm}0.1\;mg/mL)$. Ofloxacin revealed very low solubility, which the highest solubility was obtained from PEG 400 $(18.7{\pm}6.3\;mg/mL)$ among the vehicles used. The addition of lactic acid increased the solubility of ofloxacin dramatically; the solubility at 5% lactic acid was $133.7{\pm}9.7\;mg/mL$. As $2-hydroxypropyl-{\beta}-cyclodextrin$ was added at the concentrations of 40, 80, 120, 160 and 200 mM, the solubilities of lidocaine and ofloxacin were enhanced up to three and two times, respectively, with concentration-dependent pattern. Gel intermediates for filmtype patches were prepared with mucoadhesive polymer, viscosity builders, lidocaine or ofloxacin at pH values from 5 to 7. Gels were cast onto a release liner and dried at room temperature. Dried patch was attached onto an adhesive backing layer, thus forming a patch system. Patches containing a single drug component were characterized by in vitro measurement of drug release rates through a cellulose barrier membrane. The release study was carried out at $37^{\circ}C$ using a Franz-type cell. Receptor solutions were isotonic phosphate buffers (pH 7.4). Samples $(100\;{\mu}L)$ were taken over 24 hours and quantitated by a verified HPLC method. The releases from all tested were proportional to the square root of time. The release rates were 0.9, 157.3 and $281.7\;{\mu}g/cm^{2}/min^{1/2}$ for the lidocaine patches and 19.8,37.2 and $50.7\;{\mu}g/cm^{2}/min^{1/2}$ for the ofloxacin patches at the concentrations of 0.3, 0.5 and 1 %, respectively. The release rates were dose dependent in both drug patches $(R^{2}\;=\;0.9077\;for\;lidocaine;\;R^{2}\;=\;0.9949\;for\;ofloxacin)$ and those were also thickness-dependent $(R^{2}\;=\;0.9246\;for\;lidocaine;\;R^{2}\;=\;0.9512\;for\;ofloxacin)$.

Keywords

References

  1. D.F. McCafferty, A.D. Woolfson and G.P. Moss, Novel bioadhesive delivery system for percutaneous local anaesthesia. Br. J. Anaesth., 84, 456-458 (2000) https://doi.org/10.1093/oxfordjournals.bja.a013469
  2. A.D. Woolfson, D.E. McCafferty and G.P. Moss, Development and characterization of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia. Int. J. Pharm., 169, 83-94 (1998) https://doi.org/10.1016/S0378-5173(98)00109-4
  3. D.F. McCafferty and A.D. Woolfson, New patch delivery system for percutaneous local anaesthesia. Br. J. Anaesth., 71, 370-374 (1993) https://doi.org/10.1093/bja/71.3.370
  4. A.D. Woolfson, D.E. McCafferty and V. Boston, Clinical experiences with a novel percutaneous amethocaine preparation: prevention of pain due. to venepuncture in children. Br. J. Clin. Pharmacol., 30, 273-279 (1990) https://doi.org/10.1111/j.1365-2125.1990.tb03775.x
  5. T. Nagai and R. Konish, Buccal/gingival drug delivery system. J. Controlled Release, 6, 353-360 (1987) https://doi.org/10.1016/0168-3659(87)90088-5
  6. E.G. Covino, Pharmacology of local anesthetic agents. Br. J. Anaesth. 58, 701-716 (1986) https://doi.org/10.1093/bja/58.7.701
  7. M. Ishida, N. Nambu and T. Nagai, Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and Carbopol. Chem. Pharm. Bull., 30, 980-984 (1982) https://doi.org/10.1248/cpb.30.980
  8. W.J. Irwin, E.D. Sanderson and P.A. Wan, Percutaneous absorption of ibuprofen: vehicle effects on transport through rat skin. Int. J. Pharm., 66, 193-200 (1990) https://doi.org/10.1016/0378-5173(90)90399-O
  9. D.L. Larson and J.G. Lombardino, The topical anti-inflammatory effects of piroxicam in rodents. Agents and Actions, 10, 246-251 (1980) https://doi.org/10.1007/BF02025943
  10. S.C. Chi and H.W. Jun, Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell. J. Pharm. Sci., 80, 280-283 (1991) https://doi.org/10.1002/jps.2600800318
  11. Y.W. Chien, Transdermal Controlled Systemic Medications, Marcel Dekker, New York, U.S.A., pp. 1-81 (1987)
  12. Y.W. Chien and H.J. Lambert, Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanisms. J. Pharm. Sci., 63, 515-519 (1974) https://doi.org/10.1002/jps.2600630405